Matthew R. Patterson, President & CEO at Audentes Therapeutics, Inc. (BOLD), sold 27,000 shares at $38.08 ($1.0M) on 2018-05-21, disclosed to the SEC on 2018-05-23.
Open-market sale of $1.0M BOLD by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.08 | 13,600 | $518K | 50.2% |
| 2 | $38.30 | 6,700 | $257K | 24.9% |
| 3 | $38.30 | 6,700 | $257K | 24.9% |
| Total | $38.19 avg | 27,000 | $1.0M | 100% |
| Filing → |
| BOLD | SELL | 2019-02-27 | $630K | — | Filing → |
| BOLD | SELL | 2018-10-02 | $1.6M | — | Filing → |
| BOLD | SELL | 2018-09-20 | $518K | — | Filing → |